Beryl Drugs Ltd — Important, 11-03-2026: Company Update

Beryl Drugs Limited has disclosed that Sudhir Sethi, a key Promoter and Director, recently acquired an additional 11,786 equity shares through a market purchase. This transaction increases his direct ownership, now representing 0.23% of the company's total shares. Such insider buying often signals confidence from top management in the company's operational strength and future outlook, which can be viewed positively by investors watching promoter commitment.